rediff.com
India As It Happens
India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
rediff News App
Hi Guest
About 813 results for "gilead sciences"
 |
Gilead Drug For Leukemia Shows Success In Early TrialPosted 03:29 PM ET Gilead Sciences (GILD) late Wednesday announced results from the study of an experimental drug for leukemia that shrank tumors in more than half the patients tested. The pill, Idelalisib, is a treatment for patients suffering from ... Investors Business Daily, 1 day ago
Gilead Sciences to Present at the 2013 UBS Global Healthcare Conference on Monday, May 20
- EON, 11 hours ago
More from: PYMNTS.com, CNBC...and 64 other sources
|
See all (58) images for "gilead sciences" | ||||
See all (58) images for "gilead sciences"
Gilead Sciences Given Overweight Rating at JPMorgan Chase (GILD)Gilead Sciences (NASDAQ: GILD) GILD has been the subject of a number of other recent research reports. Analysts at TheStreet reiterated a "buy" rating on shares of Gilead Sciences in a research note to investors on Wednesday, May 8th. Separately, ... American Banking News, 7 hours ago
Gilead Sciences Shares Up 89.8% Since SmarTrend's Buy Recommendation (GILD)
Individual.com, 1 week ago
Gilead Sciences's Outperform Rating Reaffirmed at BMO Capital Markets (GILD)
American Banking News, 1 week ago
Gilead Sciences Has Returned 87.2% Since SmarTrend Recommendation (GILD)
Individual.com, 2 weeks ago
|
MSN Money
|
Data from Gilead's latest drug shows promiseGilead Sciences, Inc. (GILD) recently presented encouraging data on its pipeline candidate, the leukemia drug idelalisib (formerly GS-1101), from a phase II study. That study is evaluating idelalisib, combined with Roche Holding AG's (RHHBY) ... MSN Money, 1 day ago
Pipeline Progress at Gilead
Yahoo! Finance, 1 day ago
Pipeline Progress at Gilead - Analyst Blog
Zacks.com, 1 day ago
Gilead speeds ahead on idelalisib with promising leukemia data
FierceBiotech, 1 day ago
|
Scleroderma Experts from Johns Hopkins, Northwestern and Stanford to Explain Symptoms and Treatment OptionsA Free Webinar provided by the Scleroderma Research Foundation with support from Gilead Sciences, MedImmune and Novartis PR Newswire SAN FRANCISCO, May 16, 2013 SAN FRANCISCO, May 16, 2013 /PRNewswire-USNewswire/ -- The nonprofit Scleroderma ... Reuters, 1 day ago
|
CNBC
|
Lightning Round: Starbucks, Gilead & MoreAre you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites. Gilead Sciences (GILD): I think this company is terrific, said Cramer. However, biotechs have been coming in so I'd buy a quarter position ... CNBC, 1 day ago
|
Gilead anuncia datos de respuesta del estudio de Fase 2 de idelalisib para leucemia linfática crónica no tratada con anterioridadGilead Sciences, Inc. (Nasdaq: GILD) ha anunciado los resultados de un estudio de Fase 2 (estudio 101-08) que evalúa idelalisib (anteriormente GS-1101), un inhibidor oral de PI3K delta en fase de investigación, objetivado, en combinación con ... TMC Net, 1 day ago
|
Gilead Sciences (GILD) Showing Bullish Technicals But Could Break Through $57.51 ResistanceGilead Sciences Inc (NASDAQ: GILD) closed Tuesday's trading session at $56.25. In the past year, the stock has hit a 52-week low of $24.12 and 52-week high of $56.35. Gilead Sciences (GILD) stock has been showing support around $53.77 and resistance ... Individual.com, 2 days ago
Gilead Sciences (GILD) Could Break Through $53.71 Resistance Level
Individual.com, 2 weeks ago
More from: , Select Sector SPDRs...and 1 other sources
|
Buyers Accumulate Shares of Gilead Sciences, Up 2.3%(Financial News Network On) One of today's notable stocks on the rise is Gilead Sciences (NASDAQ:GILD), up 2.3% to $54.10. The Dow Jones Industrial Average is now trading fractionally lower to 15,091 and the S&P is trading fractionally lower to ... Individual.com, 4 days ago
Buyers Accumulate Shares of Gilead...
Financial News Network online, 4 days ago
US STOCKS SNAPSHOT-Nasdaq up 1 pct as Wall St extends advance
Sify, 2 weeks ago
|
Form 4 GILEAD SCIENCES INC For: May 08 Filed by: Cogan John FrancisBusinessWeek, 1 week ago Form 8-K GILEAD SCIENCES INC For: May 08 Street Insider, 4 days ago |
Reveal Insider Trading in J.C. Penney, Gilead Sciences, Chesapeake Energy, Annaly Capital Management, Endo Health Solutions, and Zynga/PRNewswire/ -- Insiderslab.com has issued insider trading reports for stock investing: J.C. Penney (NYSE:JCP), Gilead Sciences (NASDAQ:GILD), Chesapeake Energy (NYSE:CHK), Annaly Capital Management (NYSE:NLY), Endo Health Solutions (NASDAQ:ENDP), ... TickerTech.com, 3 days ago
How Insiders Trade Hot Stocks: Facebook, Microsoft, Comcast, Freeport-McMoRan Copper & Gold, Coca-Cola, and Gilead Sciences
AndhraNews.net, 6 days ago
More from: , Select Sector SPDRs...and 5 other sources
|
Prev
| Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
►AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts
rediff News App
Related Queries - gilead sciences
Alerts
Get updated on latest news & your favorite topics right in your inbox!
Widget
Get Realtime News on your webpage & get your members hooked!
Happening by Location
Click on any location on map to view latest news by location
